Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Cervical Cancer

Free Subscription 20.04.2026 1 Acad Radiol 1 Acta Biochim Biophys Sin (Shanghai) 2 AIDS Behav 1 AMB Express 1 Ann Afr Med 1 Ann Surg Oncol 1 Biochim Biophys Acta Mol Cell Res 1 BioData Min 4 BMC Cancer 1 BMC Med Educ 1 BMC Public Health 1 BMC Womens Health 1 BMJ Sex Reprod Health 1 Cancer Epidemiol 3 Cancers (Basel) 1 Cell Death Discov 1 Clin Lab 1 Contemp Clin Trials 1 Cureus 1 Curr Med Imaging 1 Diagn Cytopathol 1 EBioMedicine 1 Exp Cell Res 1 Front Immunol 1 Front Med (Lausanne) 1 Front Oncol 1 Ginekol Pol 1 Health Promot Int 1 Healthcare (Basel) 1 Hereditas 1 Int J Gynaecol Obstet 4 Int J Gynecol Cancer 2 Int J Gynecol Pathol 1 Int J Health Policy Manag 1 J Acquir Immune Defic Syndr 1 J Appl Clin Med Phys 1 J Immigr Minor Health 1 J Infect Public Health 1 J Med Case Rep 5 J Med Virol 1 J Natl Cancer Inst 1 J Obstet Gynaecol India 1 JAMA Netw Open 1 Lab Invest 1 Med Phys 1 Medicina (B Aires) 1 Mol Biol Rep 1 Neoplasia 1 Pak J Med Sci 1 PLOS Glob Public Health 1 Purinergic Signal 1 Radiat Oncol 1 Rev Bras Ginecol Obstet 4 Sci Rep 2 Transl Cancer Res 1 Womens Health Nurs 1 World J Surg Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acad Radiol

1. MARTIN-NOGUEROL T, Lopez-Ubeda P, Barrientos-Manrique EA, Garcia-Ferrer M, et al
   Towards Automated FIGO Staging in Radiology: The Role of LLMs in Cervical and Endometrial Cancer.
   Acad Radiol. 2026;33:1545-1555.
   PubMed         Abstract available
   
   

   
   Acta Biochim Biophys Sin (Shanghai)

2. YAN Y DAGGER, Bai D dagger, Li L, Xu L, et al
   Distinct miR319a identified from Persicaria chinensis mediates cross-kingdom suppression of cervical cancer by targeting ITGA3.
   Acta Biochim Biophys Sin (Shanghai). 2026 Apr 13. doi: 10.3724/abbs.2026010.
   PubMed         Abstract available
   
   

   
   AIDS Behav

3. JIBA DF, Turay P, Baldeh M, Kamara MN, et al
   Human Papillomavirus Vaccine Hesitancy and Uptake Among Adolescent Girls Living with HIV in Sierra Leone: A Call for Integration of Cervical Cancer Services.
   AIDS Behav. 2026 Apr 11. doi: 10.1007/s10461-026-05065.
   PubMed         Abstract available
   
   
4. KABARAMBI A, Kizito S, Girma AZ, Nartey P, et al
   Preliminary Impact of Public Health Messaging on HPV Vaccine Uptake Among Adolescent Girls and Young Women Living with HIV in Central Uganda.
   AIDS Behav. 2026;30:1202-1210.
   PubMed         Abstract available
   
   

   
   AMB Express

5. TIAN D, Deng L, Lu E, Li H, et al
   Lactobacillus crispatus attenuates Escherichia coli-induced inflammation and migration of cervical cancer cells.
   AMB Express. 2026 Apr 16. doi: 10.1186/s13568-026-02055.
   PubMed        
   
   

   
   Ann Afr Med

6. IFEBI CO, Chigbu CO, Ajah LO, Aniebue UU, et al
   Cervical Cancer Screening among Human Immunodeficiency Virus-positive Women: A Comparison of Outcome between Visual Inspection with Acetic Acid and Papanicolaou Smear Cytology.
   Ann Afr Med. 2026 Apr 17. doi: 10.4103.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

7. PAVONE M, Teodorico E, Bizzarri N, Innocenzi C, et al
   From Avoiding Empty Packets to Real-Time Diagnosis: The Value of Robotic Ultrasound-Guided Surgery in Sentinel Lymph Node Dissection.
   Ann Surg Oncol. 2026;33:4763-4764.
   PubMed         Abstract available
   
   

   
   Biochim Biophys Acta Mol Cell Res

8. LI Z, Zhao Z, Zhang Y, Xie Z, et al
   A nanoplatform for hypoxia-responsive co-delivery of an NQO1 enzyme-responsive pterostilbene prodrug and phenanthriplatin for multi-mechanistic cervical cancer therapy.
   Biochim Biophys Acta Mol Cell Res. 2026 Apr 8:120145.
   PubMed         Abstract available
   
   

   
   BioData Min

9. ATTALLAH O
   Light-XAI: a CADx for explainable cervical cancer detection via attention-based lightweight convolutional neural networks and layer-wise feature fusion.
   BioData Min. 2026;19:26.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. YANG X, Xie Y, Gao C, Sun N, et al
    Noninvasive prediction of lymph-vascular space invasion in cervical cancer based on ultrasomics nomogram.
    BMC Cancer. 2026 Apr 13. doi: 10.1186/s12885-026-15981.
    PubMed        
    
    
11. SORI DA, Ali R, Jibat N, Adissu W, et al
    Clinicopathologic characteristics and predictors of treatment uptake among patients with cervical cancer managed at Jimma University Medical Center, Southwest Ethiopia.
    BMC Cancer. 2026 Apr 14. doi: 10.1186/s12885-026-15987.
    PubMed        
    
    
12. USIN SG, Olajire GA, Olumese JO, Idenyi EO, et al
    Transcriptomic profiling of select genes associated with cervical cancer and its preneoplastic lesions in Nigerian patients: an in vivo and in silico study.
    BMC Cancer. 2026 Apr 16. doi: 10.1186/s12885-026-15972.
    PubMed        
    
    
13. ZHAO Y, Zhao C, Liu Y, Wang Y, et al
    Prognostic prediction in primary cervical squamous cell carcinoma with serum squamous cell carcinoma antigen >/= 10 ng/mL: development and validation of a nomogram model based on inflammatory biomarkers and clinical factors.
    BMC Cancer. 2026;26:479.
    PubMed         Abstract available
    
    

    
    BMC Med Educ

14. GU Z, Liu Y, Liang Y, Lian X, et al
    Enhancing the precision and uniformity of clinical target volume delineation for cervical cancer through a structured educational program.
    BMC Med Educ. 2026 Apr 13. doi: 10.1186/s12909-026-09203.
    PubMed        
    
    

    
    BMC Public Health

15. JIA M, Wapmuk A, Gbaja-Biamila T, Abudulrasheed OA, et al
    Knowledge, attitudes, and practices of cervical cancer preventive services among mothers living with HIV in Lagos, Nigeria: a cross-sectional study.
    BMC Public Health. 2026 Apr 16. doi: 10.1186/s12889-026-27320.
    PubMed        
    
    

    
    BMC Womens Health

16. WU Y, Zhang Y, Qian X, Li Y, et al
    The association of fungal infection in cervical cancer: a systematic review and meta-analysis.
    BMC Womens Health. 2026 Apr 17. doi: 10.1186/s12905-026-04451.
    PubMed         Abstract available
    
    

    
    BMJ Sex Reprod Health

17. BONAR G, Cameron S
    Human papillomavirus vaccination and cervical screening uptake among women presenting for abortion: exploring opportunities for health care interventions.
    BMJ Sex Reprod Health. 2026;52:95-100.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol

18. VILAKATI LN, Ndlela MG, Hlophe NP, Liu JJ, et al
    Comparison of early-onset and later-onset cervical cancer clinical characteristics and trends in Eswatini.
    Cancer Epidemiol. 2026;102:103071.
    PubMed         Abstract available
    
    

    
    Cancers (Basel)

19. TRZESZCZ M, Mazurec K, Mazurec M, Kobierzycki C, et al
    Informative High-Risk HPV Genotyping in Cervical Cancer Screening: Integrated Analysis of Cytology and p16/Ki67 Dual Staining.
    Cancers (Basel). 2026;18:1056.
    PubMed         Abstract available
    
    
20. LANCELLOTTA V, La Milia MC, Autorino R, Rosa E, et al
    Development of an Enomogram to Predict the Rate of Loco-Regional Control After Radio-Chemotherapy and Interventional Radiotherapy in Cervical Cancer.
    Cancers (Basel). 2026;18:1096.
    PubMed         Abstract available
    
    
21. PHIANPISET R, Detwongya C, Manopunya M, Cheewakriangkrai C, et al
    Prognostic Survival Model Following Primary Radical Surgery for Early-Stage Cervical Cancer.
    Cancers (Basel). 2026;18:1134.
    PubMed         Abstract available
    
    

    
    Cell Death Discov

22. CHEN C, Zhang F, Shen J, Zheng Q, et al
    Correction: CLC3 regulates V-ATPase to enhance lysosomal degradation and cisplatin resistance in cervical cancer cells.
    Cell Death Discov. 2026;12:184.
    PubMed        
    
    

    
    Clin Lab

23. GUO L, Yuan X, Zhou Y, Zhang D, et al
    Immune Cells and Risk of Cervical Cancer: Evidence from a Mendelian Randomization Study.
    Clin Lab. 2026;72.
    PubMed         Abstract available
    
    

    
    Contemp Clin Trials

24. CHIBWESHA CJ, Mollan KR, Teodoro NS, Keys JR, et al
    Randomized clinical trial protocol: Acceptability and feasibility of combination treatment for cervical precancer among South African women living with HIV (ACT 2).
    Contemp Clin Trials. 2026;164:108272.
    PubMed         Abstract available
    
    

    
    Cureus

25. WOITTIEZ L, Soekdew A, Dams E, Brinkman K, et al
    Cervical Cancer Screening in Women Living With HIV in Suriname.
    Cureus. 2026;18:e105234.
    PubMed         Abstract available
    
    

    
    Curr Med Imaging

26. QI W, Liao F, Luo Z, Shao M, et al
    Clinical and 18F-FDG PET/CT Imaging Characteristics of Post-radiotherapy Sacral Insufficiency Fractures in Cervical Cancer Patients.
    Curr Med Imaging. 2026 Apr 8. doi: 10.2174/0115734056428627260223054010.
    PubMed         Abstract available
    
    

    
    Diagn Cytopathol

27. ZHOU S, Chen S, Xu S
    Establishment of a Methodology for PAX1 and CADM1 Methylation Detection and Preliminary Assessment of Its Clinical Value for Cervical Cancer Diagnosis.
    Diagn Cytopathol. 2026 Apr 16. doi: 10.1002/dc.70123.
    PubMed         Abstract available
    
    

    
    EBioMedicine

28. DAI Y, Huang F, Li X, Wu W, et al
    Development and preclinical evaluation of KDTV001, an adenovirus 5-vectored trivalent HPV therapeutic vaccine targeting HPV16/18/52.
    EBioMedicine. 2026;126:106230.
    PubMed         Abstract available
    
    

    
    Exp Cell Res

29. ZHAN F, Zhong Y, Qin Y, Li L, et al
    Retraction notice to "SND1 facilitates the invasion and migration of cervical cancer cells by Smurf1-mediated degradation of FOXA2" [Exp. Cell Res. 388 (2020) 111809].
    Exp Cell Res. 2026 Apr 10:115008. doi: 10.1016/j.yexcr.2026.115008.
    PubMed        
    
    

    
    Front Immunol

30. LI Q, Zeng J, Li X, Huang M, et al
    Case Report: Two cases of primary malignant melanoma of the female genital tract and literature review.
    Front Immunol. 2026;17:1797752.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

31. HE G, Liang J, Ding Z, Qu X, et al
    KDM5B recruits FOXG1 to suppress the IFN response, leading to malignant progression and immune evasion in cervical cancer.
    Front Med (Lausanne). 2026;13:1749536.
    PubMed         Abstract available
    
    

    
    Front Oncol

32. YANG Y, Zhang G, Shang H, Fu X, et al
    Tumor apparent diffusion coefficient as a predictive marker for PD-1 inhibitor outcome in advanced cervical cancer: a retrospective study.
    Front Oncol. 2026;16:1769071.
    PubMed         Abstract available
    
    

    
    Ginekol Pol

33. BOCHNIAK K, Nitsch-Osuch A, Zamudio Padilla JD, Prusaczyk A, et al
    Systemic recommendations on the promotion of HPV vaccinations based on international social marketing campaigns.
    Ginekol Pol. 2026;97:233-238.
    PubMed         Abstract available
    
    

    
    Health Promot Int

34. BHETWAL B, Sharma V, Abbott A, Schafer EJ, et al
    Cervical cancer prevention behaviors and determinants among Indigenous women in rural Nepal.
    Health Promot Int. 2026;41:daag042.
    PubMed         Abstract available
    
    

    
    Healthcare (Basel)

35. KAMASHIDZE K, Beruchashvili T, Peshkova T, Nakashidze I, et al
    Physician-Level Determinants of Cervical Cancer Screening Practices: A Socio-Ecological Model-Based Study from Adjara, Georgia.
    Healthcare (Basel). 2026;14:961.
    PubMed         Abstract available
    
    

    
    Hereditas

36. OLVERA-VALENCIA M, Grijalva-Perez A, Millan-Catalan O, Albino-Sanchez ME, et al
    Cellular plasticity and heterogeneity underlying therapy resistance in 3D cervical cancer models.
    Hereditas. 2026 Apr 14. doi: 10.1186/s41065-026-00668.
    PubMed        
    
    

    
    Int J Gynaecol Obstet

37. JIAMSET I, Nanthamongkolkul K, Kongkamsuan W, Saeaib N, et al
    Neutrophil-to-lymphocyte ratio as a prognostic marker for survival outcomes in women with cervical cancer and HIV infection.
    Int J Gynaecol Obstet. 2026 Apr 14. doi: 10.1002/ijgo.71016.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

38. CHO O, El Naqa I
    Prognostic impact of pelvic bone magnetic resonance imaging features in patients with cervical cancer undergoing definitive concurrent chemoradiotherapy.
    Int J Gynecol Cancer. 2026;36:104648.
    PubMed         Abstract available
    
    
39. VANDECAVEYE V, Walgraeve MS, De Keyzer F, Vergote I, et al
    Pre-operative assessment in International Federation of Gynaecology and Obstetrics-2009 stage IB2 to IIB cervical cancer: role of delayed gadolinium-enhanced magnetic resonance imaging after neoadjuvant chemotherapy.
    Int J Gynecol Cancer. 2026;36:104650.
    PubMed         Abstract available
    
    
40. SILVA NETO ALD, Mattos JM, Scaranti M
    Beyond viral detection: refining biological risk stratification in human papillomavirus-positive cervical cancer screening.
    Int J Gynecol Cancer. 2026;36:104658.
    PubMed        
    
    
41. SONG M, Bandoni K, Rodriguez-Rodriguez L, Nelson RA, et al
    Disparities between Blacks and Whites in risk of second primary malignancies among patients with cervical cancer: analysis of Surveillance, Epidemiology, and End Results Database.
    Int J Gynecol Cancer. 2026;36:104637.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Pathol

42. RYAN M, Riain CO, Thodi G, Finn S, et al
    Dedifferentiated Cervical Mesonephric Adenocarcinoma: Report of 2 Cases of a Previously Undescribed Phenomenon.
    Int J Gynecol Pathol. 2026;45:210-216.
    PubMed         Abstract available
    
    
43. XU J, Li Q, Weisman PS
    HPV-associated Endocervical Adenocarcinoma In Situ (AIS) With an ER+/Vimentin+/CEA- immunophenotype Mimicking Tubo-endometrioid Metaplasia.
    Int J Gynecol Pathol. 2026;45:246-248.
    PubMed         Abstract available
    
    

    
    Int J Health Policy Manag

44. RAHMAN MT, Mahmood S, Attwell K
    Religion, Politics, and Vaccines: Elaborating the Integrative Public Policy Acceptance (IPAC) Framework Through HPV Vaccine Program Acceptance Among Religious Leaders in Bangladesh.
    Int J Health Policy Manag. 2026;15:9179.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

45. MCCORMICK LJ, Gillot M, Ussery F, Bihini C, et al
    Cervical cancer screening coverage increased in Malawi, Tanzania, Zambia, and Zimbabwe: Findings from sequential Population-based HIV Impact Assessment Surveys 2015-2017 and 2020-2023.
    J Acquir Immune Defic Syndr. 2026 Apr 15. doi: 10.1097/QAI.0000000000003880.
    PubMed         Abstract available
    
    

    
    J Appl Clin Med Phys

46. 
    Correction to: "Impact of rectal gas evacuation on dosimetry and applicator displacement in cervical cancer brachytherapy".
    J Appl Clin Med Phys. 2026;27:e70549.
    PubMed        
    
    

    
    J Immigr Minor Health

47. ABBAS S, Teague K, Lakin K, Bari K, et al
    Cervical Screening Experiences among Culturally and Linguistically Diverse Muslim Women in Australia: A Scoping Review.
    J Immigr Minor Health. 2026;28:489-504.
    PubMed         Abstract available
    
    

    
    J Infect Public Health

48. HUANG CY, Chang CY, You SL, Tsai HT, et al
    Recurrent cytologic inflammation on cervical smear and risk of low-grade cervical abnormalities in cytology-based screening: A 25-year multicenter cohort study from HPV-resource-limited settings.
    J Infect Public Health. 2026;19:103192.
    PubMed         Abstract available
    
    

    
    J Med Case Rep

49. GE Z, Wang X, Zhang Z, Li J, et al
    Synchronous atypical lobular endocervical glandular hyperplasia of the cervix and endometrium: a clinicopathologic case report and review of literature.
    J Med Case Rep. 2026;20:191.
    PubMed         Abstract available
    
    

    
    J Med Virol

50. CHOKWASSANASAKULKIT T, Ranasinghe V, Woods E, Nguyen LQ, et al
    What If Trojan Horse Nanoparticles Could Change the Game for HPV Gene-Targeted Therapies?
    J Med Virol. 2026;98:e70916.
    PubMed         Abstract available
    
    
51. LEI T, Wang F, Zhang S, Zhang L, et al
    Tumor Core-Edge Divergence in T-Cell Exhaustion and Clonal Expansion in HPV-Related Cervical Squamous Cell Carcinoma Unveiled by Simultaneous Single-Cell RNA and TCR Sequencing.
    J Med Virol. 2026;98:e70912.
    PubMed         Abstract available
    
    
52. KOLIGUDDE V, Agarwal M, Marbaniang E, Shinde P, et al
    Beyond HPV-16 and 18: Clinical Significance of HPV-58 and 59 in Cervical Abnormalities in Northeast India.
    J Med Virol. 2026;98:e70924.
    PubMed         Abstract available
    
    
53. LEMOINE V, Legros R, Rosec S, Salaun C, et al
    Negative Xpert HPV Test (Cepheid) With Late Amplification Signals: Is There a Clinical Significance? (the PaPCR Study).
    J Med Virol. 2026;98:e70915.
    PubMed         Abstract available
    
    
54. NOVAK EN, Ma A, Hansen CJ, Wazir Z, et al
    Mock Samples That Mimic Human Cervicovaginal Samples to Accelerate the Development and Evaluation of Assays for High-Risk HPV for Cervical Cancer Screening.
    J Med Virol. 2026;98:e70931.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

55. SEMPRINI J
    RE: State-level progress in reducing cervical cancer incidence among US young women between the pre- and post-human papillomavirus vaccination eras.
    J Natl Cancer Inst. 2026 Apr 15:djag116. doi: 10.1093.
    PubMed        
    
    

    
    J Obstet Gynaecol India

56. CHUGH M, Goel B, Sehgal A, Dubey S, et al
    Revolutionizing Community-Based Cervical Cancer Screening: Evaluating an Indigenous Artificial Intelligence-Enabled Portable Colposcope.
    J Obstet Gynaecol India. 2026;76:42-48.
    PubMed         Abstract available
    
    

    
    JAMA Netw Open

57. LEVY MS, Huang M, Dietrich CS, Fabian D, et al
    Oncology Clinicians' Attitudes on Hormonal Therapy After Chemoradiotherapy for Cervical Cancer.
    JAMA Netw Open. 2026;9:e266862.
    PubMed        
    
    

    
    Lab Invest

58. DONG X, Corbin H, Zhang X, Bai X, et al
    Comprehensive Assessment of Artificial Intelligence as a Stand-alone tool for Cervical Cancer Screening Using a 50% Negative Cutoff Value.
    Lab Invest. 2026 Apr 9:106126. doi: 10.1016/j.labinv.2026.106126.
    PubMed         Abstract available
    
    

    
    Med Phys

59. JIAN W, Zhu L, Zhang B, He Q, et al
    Megavoltage CT enhancement for cervical cancer tomotherapy using a generative adversarial network with deformable convolution and self-attention.
    Med Phys. 2026;53:e70416.
    PubMed         Abstract available
    
    

    
    Medicina (B Aires)

60. MONTIEL S, Pasaca C, Lopepe M, Gorosito F, et al
    [Post-hysterectomy chyloascites: A rare complication].
    Medicina (B Aires). 2026;86:526-528.
    PubMed         Abstract available
    
    

    
    Mol Biol Rep

61. CHERAGHI P, Khalaj-Kondori M, Moqadami A
    Epithelial-mesenchymal transition and its role in drug resistance of cervical cancer.
    Mol Biol Rep. 2026;53:618.
    PubMed        
    
    

    
    Neoplasia

62. LOU H, Langan D, Syracuse N, Murphy EA, et al
    PIK3CA mutant cervical cancer is selectively suppressed by PI3Kalpha inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy.
    Neoplasia. 2026;76:101305.
    PubMed         Abstract available
    
    

    
    Pak J Med Sci

63. LI J, Su Y, Chen L, An Y, et al
    Association of CDK15 and L1CAM Expression in Cervical Cancer Tissues with Clinicopathological Characteristics and Recurrence/Metastasis After Radical Hysterectomy.
    Pak J Med Sci. 2026;42:621-628.
    PubMed         Abstract available
    
    

    
    PLOS Glob Public Health

64. MSIBI SS, Lopez C, Khumalo FN, Su LJ, et al
    Predictors of survival among cervical cancer patients in Swaziland (Eswatini): A population-based analysis in a resource-limited setting (2016-2024).
    PLOS Glob Public Health. 2026;6:e0006309.
    PubMed         Abstract available
    
    

    
    Purinergic Signal

65. XIONG HY, Li R, Hu XM, Zhang Y, et al
    P2X7 receptor mediates the anti-tumor effect of running on cervical cancer in mice.
    Purinergic Signal. 2026;22:39.
    PubMed         Abstract available
    
    

    
    Radiat Oncol

66. NING B, Liang X, Cui Z, Li Y, et al
    A deep learning-driven automated treatment planning framework for cervical cancer patients treated with volumetric modulated arc therapy.
    Radiat Oncol. 2026 Apr 14. doi: 10.1186/s13014-026-02842.
    PubMed         Abstract available
    
    

    
    Rev Bras Ginecol Obstet

67. DA ROCHA KC, Castanha EB, Elias MEM, da Silva CML, et al
    Human papillomavirus-based vs. cytology for cervical cancer screening: a systematic review with meta-analysis.
    Rev Bras Ginecol Obstet. 2026;48:e-rbgo130.
    PubMed         Abstract available
    
    

    
    Sci Rep

68. AHMADI M, Yoosefian M
    Integrated computational screening of FDA-approved anticancer drugs as novel HPV-16 E6 inhibitors in cervical cancer.
    Sci Rep. 2026 Apr 14. doi: 10.1038/s41598-026-42656.
    PubMed        
    
    
69. ZHONG P, Li W, Feng M, Guo A, et al
    METTL3-mediated m(6)A modification stabilizes circCDK6 to promote cervical cancer tumorigenesis via the miR-449a/CDK6 axis.
    Sci Rep. 2026 Apr 16. doi: 10.1038/s41598-026-47660.
    PubMed        
    
    
70. JAHAN N, Hossain MS, Ariful Kabir KM
    Analyzing the impact of gender-specific vaccination strategies and behavioral dynamics on HPV transmission.
    Sci Rep. 2026;16:12115.
    PubMed         Abstract available
    
    
71. WALLE M, Mulatie Z, Cherie N, Ibrahim AM, et al
    Hematological parameters as predictive indicators of disease stage in patients with cervical cancer.
    Sci Rep. 2026 Apr 17. doi: 10.1038/s41598-026-47004.
    PubMed         Abstract available
    
    

    
    Transl Cancer Res

72. WANG ZX, Chang LL, Liu J, Wu DM, et al
    A retrospective cohort study comparing long-term clinical outcomes between patients with and without neoadjuvant therapy in stage IB-IIB cervical cancer: a propensity score-matched study.
    Transl Cancer Res. 2026;15:201.
    PubMed         Abstract available
    
    
73. DONG S, Liu W, Yu D, Zhang X, et al
    Co-assembled structures of Fe(3)O(4) nanoparticles for therapy of cervical cancer by inducing apoptosis and autophagy.
    Transl Cancer Res. 2026;15:150.
    PubMed         Abstract available
    
    

    
    Womens Health Nurs

74. ABUZEYAD RN, Ali NA, Twalbeh DA
    Effect of a culturally tailored educational intervention on women's knowledge and attitudes toward cervical cancer screening: a single-group pre-post study.
    Womens Health Nurs. 2026;32:52-63.
    PubMed         Abstract available
    
    

    
    World J Surg Oncol

75. ZHANG L, Yang J, Zhang P, Shang Y, et al
    Association between log odds of positive lymph nodes and survival in surgically treated cervical cancer patients: a SEER database-based cohort study.
    World J Surg Oncol. 2026 Apr 18. doi: 10.1186/s12957-026-04353.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum